

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Necitumumab ni umuti w'indwara ya kanseri ugamije gufasha kuvura ubwoko bwihariye bwa kanseri y'ibihaha yitwa squamous non-small cell lung cancer. Uyu muti ukora ubu byose buhagarika poroteyine zifasha selile za kanseri gukura no gukwirakwira mu mubiri wawe.
Niba muganga wawe yaravuze kuri necitumumab nk'igice cy'ubuvuzi bwawe, birashoboka ko ufite ibibazo byerekeye uko ikora n'icyo witegura. Reka tunyuremo ibintu byose ukeneye kumenya kuri uyu muti mu buryo bworoshye kandi bugaragara.
Necitumumab ni umuti ukorwa muri laboratori ugamije selile za kanseri by'umwihariko. Tekereza nk'igisasu kiyobowe kigenda gishakisha kigafatana na selile za kanseri mu gihe kireka selile zawe nyinshi zifite ubuzima bwiza.
Uyu muti ubarirwa mu cyiciro cy'imiti yitwa monoclonal antibodies. Izi ni poroteyine zidasanzwe zishobora kumenya no kwifatanya n'intego zihariye kuri selile za kanseri. Iyo imaze kwifatanya, necitumumab ifasha guhagarika kanseri gukura kandi ishobora gufasha urwego rwawe rw'ubudahangarwa kurwanya indwara neza.
Uzahabwa necitumumab binyuze mu gutera urushinge rwa IV mu kigo kivura kanseri cyangwa mu bitaro. Uyu muti uza nk'amazi asobanutse avangwa n'umuti wa saline mbere yo guhabwa binyuze mu muyoboro w'imitsi.
Necitumumab yemejwe by'umwihariko kuvura kanseri y'ibihaha ya squamous non-small cell lung cancer yageze mu bindi bice by'umubiri wawe. Muganga wawe azandika uyu muti gusa niba kanseri yawe ifite ubwo bwoko bwihariye bwa selile ya squamous.
Muri rusange uzahabwa necitumumab ihujwe n'imiti ya chemotherapy yitwa gemcitabine na cisplatin. Ubu buryo bwo guhuza akenshi bukora neza kurusha chemotherapy yonyine kuko buri muti utera kanseri mu buryo butandukanye.
Umuvuzi wawe w’indwara z’umwijima azemeza ko necitumumab ikwiriye kuri wowe binyuze mu bizami bitandukanye. Ibi bishobora gukubiyemo ibizamini by’ibice by’umubiri byafashwe ku mwijima wawe ndetse n’ibizamini byerekana uko indwara yafashe intera.
Necitumumab ikora ibuza poroteyine yitwa EGFR (epidermal growth factor receptor) yicara ku gice cy’inyuma cy’uturemangingo tw’umwijima. Iyi poroteyine isanzwe ifasha uturemangingo gukura no kwigabanya, ariko uturemangingo tw’umwijima akenshi tuba dufite nyinshi.
Iyo necitumumab yifatanyije na EGFR, biba bimeze nk’ugushyira urufunguzo ku rugi uturemangingo tw’umwijima dukoresha kugira ngo twakire ibimenyetso byo gukura. Ibi bifasha kugabanya cyangwa guhagarika umwijima gukura no gukwirakwira mu bice bishya by’umubiri wawe.
Uyu muti ufashwe nk’uvura umwijima ku buryo buciriritse. Nubwo atari nk’imiti imwe ya shimi, iracyasaba gukurikiranwa neza kandi ishobora gutera ingaruka zikomeye zizakurikiranwa n’ikipe yawe y’abaganga.
Uzahabwa necitumumab binyuze mu gutera urushinge ruzamara iminota nka 60. Ikipe yawe y’ubuvuzi izaguha uyu muti ahantu havurirwa umwijima aho bazagukurikiranira hafi mu gihe cyo gutera urushinge no nyuma yarwo.
Mbere ya buri vuzi, birashoboka ko uzahabwa imiti ifasha kwirinda ibimenyetso by’uburwayi. Ibi bishobora kuba harimo imiti irwanya allergie nka Benadryl cyangwa imiti ya steroid kugira ngo igabanye amahirwe yo kwibasirwa n’urushinge.
Ntabwo ukeneye kwirinda kurya mbere yo guhabwa necitumumab, ariko kuguma ufite amazi menshi unywa amazi menshi bishobora gufasha umubiri wawe gukora neza uyu muti. Umuforomo wawe azanaguha amazi mu gihe cyo kuvurwa.
Gahunda yo gutera urushinge isanzwe ikurikiza uburyo uha necitumumab ku munsi wa 1 n’uwa 8 mu gihe cy’iminsi 21 yo kuvurwa. Muganga wawe azahindura iki gihe bitewe n’uko urimo witwara neza mu kuvurwa n’uko wumva umeze.
Ubugufi bw'imiti ya necitumumab buratandukana cyane ku muntu ku muntu. Abantu bamwe bayihabwa mu mezi menshi, abandi bakaba bayikomeza umwaka cyangwa barenga niba ikora neza kandi ingaruka zikaba zicungwa neza.
Umuvuzi wawe w'indwara z'umwijima azajya agenzura uko kanseri yawe yitwara binyuze mu maso n'ibizamini by'amaraso. Niba kanseri itangiye kongera gukura cyangwa niba ingaruka zikomeye cyane, muganga wawe azaganira ku guhagarika necitumumab no gushakisha ubundi buryo bwo kuvura.
Ibyemezo byo kuvura biterwa n'ibintu byinshi birimo uko wumva umeze, ibisubizo byawe by'amaso, n'ubuzima bwawe muri rusange. Itsinda ryawe ry'abaganga rizagirana nawe ibiganiro by'ukuri ku bijyanye no gukomeza cyangwa guhindura gahunda yawe yo kuvura uko igihe kigenda gihita.
Kimwe n'imiti myinshi ya kanseri, necitumumab ishobora gutera ingaruka, nubwo atari buri wese uzihura kimwe. Kumva ibishobora kuba byagufasha kumva witeguye kandi ukamenya igihe cyo kuvugana n'itsinda ryawe ry'ubuzima.
Ingaruka zisanzwe ushobora guhura nazo zirimo ibibazo by'uruhu, ibisebe mu kanwa, n'imihindagurikire y'amaraso yawe muganga wawe azagenzura binyuze mu bizamini bisanzwe byo mu laboratori.
Izi ngaruka zibaho ku bantu benshi bafata necitumumab, ariko akenshi ziracungwa neza bitewe n'ubwitange n'ubuvuzi bukwiye:
Itsinda ryawe ry'ubuzima rifite uburambe mu gucunga izi ngaruka kandi rishobora gutanga imiti cyangwa inama zo kugufasha kumva umeze neza. Ibibazo byinshi muri ibi bikosoka uko igihe kigenda gihita cyangwa igihe kuvurwa kurangira.
Nubwo bitajyenda kenshi, ingaruka zimwe na zimwe zishobora gusaba ubufasha bwihutirwa. Kumenya ibimenyetso by'imburira bifasha kubona ubufasha bwihuse niba bibaye ngombwa:
Niba ubonye kimwe muri ibi bimenyetso, hamagara ikipe yawe y'abaganga b'indwara z'umwijima ako kanya cyangwa ujye mu cyumba cy'ubutabazi. Kugira gahunda yo kugera ku ikipe yawe y'ubuvuzi nyuma y'amasaha y'akazi bishobora gutanga umutuzo.
Ingaruka zimwe na zimwe zibaho gake ariko zigomba kwitabwaho. Ikipe yawe y'ubuvuzi izagenzura ibi binyuze mu kugenzura no gupima buri gihe:
Kugenzura buri gihe bifasha gufata ibi bibazo hakiri kare igihe byoroshye gukemura. Ikipe yawe y'ubuzima izahindura gahunda yawe yo kuvurwa niba hari impinduka ziteye impungenge zigaragara.
Necitumumab ntabwo ikwiriye kuri buri wese urwaye kanseri y'ibihaha. Muganga wawe azasuzuma neza amateka yawe y'ubuzima n'ubuzima bwawe bwa none mbere yo kugusaba iyi miti.
Abantu bafite ubwoko butari bwa squamous bwa kanseri y'ibihaha ntibagomba guhabwa necitumumab kuko ubushakashatsi bwerekana ko bitagira icyo bifasha kandi bishobora gutera ingaruka mbi kurusha inyungu muri ibi bihe. Muganga wawe azapima igituntu cyawe kugirango yemeze ubwoko bwa squamous mbere yo gutangira kuvurwa.
Niba ufite ibibazo bikomeye by'umutima, indwara y'impyiko, cyangwa izindi ndwara zimwe na zimwe, muganga wawe ashobora guhitamo uburyo bwo kuvura butandukanye. Bazatekereza kandi ku miti yose urimo gufata ubu kugira ngo wirinde guhura n'ibibazo bikomeye.
Kuba utwite no konsa ni ibintu by'ingenzi by'ingenzi. Necitumumab ishobora kwangiza abana bakiri bato, bityo uzakenera gukoresha uburyo bwo kuboneza urubyaro neza mugihe uvurwa no mumyaka myinshi nyuma yaho niba ushobora gutwita.
Necitumumab igurishwa ku izina ry'ubwoko rya Portrazza. Ushobora kubona izina ryombi ku nyandiko zawe z'ubuvuzi, impapuro z'ubwishingizi, cyangwa ibirango by'imiti.
Niba muganga wawe abyita necitumumab cyangwa Portrazza, bavuga umuti umwe. Amazina yombi agaragara ku byemezo byemewe n'amategeko n'imigambi yo kuvura.
Niba necitumumab itagukwiriye cyangwa ikareka gukora neza, hari ubundi buryo bwo kuvura bwo kuvura kanseri y'ibihaha idafite uturemangingo duto. Umuganga wawe w'inzobere mu by'indwara z'umutima azaganira kuri izi nzira zindi zishingiye ku miterere yawe yihariye.
Ubuvuzi bundi bwibanda ku bintu runaka nka pembrolizumab (Keytruda) cyangwa nivolumab (Opdivo) bikora muburyo butandukanye bifasha urugero rwawe rw'umubiri kurwanya kanseri. Iyi miti ikoreshwa mu kurwanya indwara zifite kanseri yerekanye icyizere mu kuvura kanseri y'ibihaha, nubwo ikora neza mu bihe bitandukanye.
Uburyo bwo kuvura gakondo ya chemotherapy bugumana uburyo bwo kuvura bw'ingenzi. Muganga wawe ashobora gushimangira carboplatin na paclitaxel cyangwa izindi mvange ziterwa n'ubuzima bwawe muri rusange n'ubuvuzi bwa mbere.
Igeragezwa ryo mu buvuzi ritanga uburyo bwo kubona uburyo bushya bwo kuvura bushobora kuzaba uburyo bwo kuvura busanzwe mu gihe kizaza. Umuganga wawe w'inzobere mu by'indwara z'umutima ashobora kugufasha gushakisha niba hari igeragezwa ririho ryakwemerera.
Necitumumab na cetuximab zombi zikoreshwa mu kurwanya EGFR, ariko zikoreshwa mu kurwanya ubwoko butandukanye bwa kanseri. Cetuximab ikoreshwa cyane mu kurwanya kanseri y'urura n'iy'umutwe n'ijosi, naho necitumumab yemerejwe by'umwihariko kurwanya kanseri y'ibihaha yitwa squamous.
Kugereranya izi miti mu buryo butaziguye biragoye kuko zivura ubwoko butandukanye bwa kanseri. Buri muti wagiye wigwaho cyane mu bwoko bwa kanseri wemerejwe kuvura kandi byagaragaye ko zitanga umusaruro iyo zikoreshejwe neza.
Umuvuzi wawe w'indwara ya kanseri azahitamo umuti ukwiriye kurwanya ubwoko bwa kanseri ufite n'uko umeze. Icyemezo ntigishingiye ku muti
Niba ubonye ibimenyetso nk'ingorane zo guhumeka, umutima ubyimba, uruhu rurwara cyane, cyangwa isereri mugihe uvurwa, bwira umuforomo wawe ako kanya. Bahuguwe kumenya no kuvura ibibazo byo kuvurwa vuba.
Itsinda ryawe rivura rishobora kugabanya cyangwa guhagarika kuvurwa by'agateganyo no kuguha imiti yo gufasha mu kuvura. Ibimenyetso byinshi byo kuvurwa birashoboka kubicunga, kandi abantu benshi barashobora gukomeza kuvurwa bafite ingamba zikwiye.
Umwanzuro wo kureka necitumumab biterwa n'uko bikora neza n'uko wihanganira kuvurwa. Umuganga wawe w'indwara z'umwijima azagenzura buri gihe uko witwara binyuze mu bipimo no mu bizami by'amaraso kugirango afate uyu mwanzuro.
Ushobora guhagarika necitumumab niba kanseri yawe ikomeje nubwo uvurwa, niba ingaruka ziba zikomeye cyane kubicunga, cyangwa niba ubonye igisubizo cyiza kandi muganga wawe agasaba guhagarika kuvurwa. Iyi myanzuro ikorwa buri gihe hagati yawe n'ikipe yawe y'ubuvuzi.
Imiti myinshi irashobora gufatwa neza hamwe na necitumumab, ariko imwe irashobora guhura cyangwa ikongera ingaruka. Buri gihe bwira umuganga wawe w'indwara z'umwijima ku miti yose, ibyongerera imbaraga, na vitamine ufata.
Itsinda ryawe ry'ubuvuzi rizasuzuma urutonde rw'imiti yawe mbere yo gutangira necitumumab kandi rishobora guhindura doze cyangwa igihe cy'indi miti. Bika urutonde rugezweho rw'imiti yawe yose kandi ujyane na yo mu gihe cyose cyo kwisuzumisha.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.